These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30076082)

  • 1. Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic Shunt.
    Cui LB; Ren S; Xi YB; Zeng LL; Chen G; Liu K; Yu T; He C; Guo W; Yin Z; Wang Z; Niu J; Luo B; Hu D; Han G; Yin H
    Acad Radiol; 2019 May; 26(5):e38-e46. PubMed ID: 30076082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain white matter fiber tracts involved in post-transjugular intrahepatic portosystemic shunt hepatic myelopathy.
    Wang LX; Guo L; Guo F; Ren SY; Fei NB; Liu K; Liu L; Yu TL; He CY; Xi YB; Tian P; Cui LB; Yin ZX; Wang ZY; Qin W; Han GH; Yin H
    Neuroreport; 2017 Dec; 28(17):1164-1169. PubMed ID: 28953093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory--a resting-state functional MRI study.
    Ni L; Qi R; Zhang LJ; Zhong J; Zheng G; Wu X; Fan X; Lu GM
    Eur J Radiol; 2014 Mar; 83(3):578-83. PubMed ID: 24299611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study.
    Liu K; Chen G; Ren SY; Zhu YQ; Yu TL; Tian P; Li C; Xi YB; Wang ZY; Ye JJ; Han GH; Yin H
    Neural Regen Res; 2019 May; 14(5):850-857. PubMed ID: 30688271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resting-state functional magnetic resonance study of brain function changes after TIPS operation in patients with liver cirrhosis].
    Liu C; Wang HB; Yu YQ; Wang MQ; Zhang GB; Xu LY; Wu JM
    Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(47):3787-3792. PubMed ID: 28057091
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study.
    Zhang LJ; Qi R; Zhong J; Xu Q; Zheng G; Lu GM
    PLoS One; 2012; 7(8):e42824. PubMed ID: 22912746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.
    Krieger S; Jauss M; Jansen O; Stiehl A; Sauer P; Geissler M; Theilmann L; Krieger D
    J Hepatol; 1997 Jul; 27(1):121-6. PubMed ID: 9252084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
    Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mid- and long-term efficacy of shunt limiting for hepatic myelopathy after transjugular intrahepatic portosystemic shunt.
    Zhao H; Liu F; Yue Z; Wang L; Fan Z
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):440-6. PubMed ID: 26724169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular liver biopsy after transjugular intrahepatic portosystemic shunt (TIPS) or direct intrahepatic portocaval shunt (DIPS): Is it feasible, effective, and safe?
    Kaufman C; Aryafar H; Minocha J; Kinney T
    Diagn Interv Imaging; 2018 May; 99(5):331-335. PubMed ID: 29366793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
    Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
    Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.
    Chen HJ; Zheng G; Wichmann JL; Schoepf UJ; Lu GM; Zhang LJ
    Metab Brain Dis; 2015 Dec; 30(6):1331-41. PubMed ID: 26404041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy
    Jiang TT; Luo XP; Sun JM; Gao J
    World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal-systemic myelopathy after transjugular intrahepatic portosystemic shunt creation: report of four cases.
    Wang MQ; Dake MD; Cui ZP; Wang ZQ; Gao YA
    J Vasc Interv Radiol; 2001 Jul; 12(7):879-81. PubMed ID: 11435545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis.
    Busk TM; Bendtsen F; Poulsen JH; Clemmesen JO; Larsen FS; Goetze JP; Iversen JS; Jensen MT; Møgelvang R; Pedersen EB; Bech JN; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G275-G286. PubMed ID: 29074483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt.
    Jalan R; Gooday R; O'Carroll RE; Redhead DN; Elton RA; Hayes PC
    J Hepatol; 1995 Dec; 23(6):697-705. PubMed ID: 8750169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.